human burkitt s lymphoma ramos (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
human burkitt s lymphoma ramos
Human Burkitt S Lymphoma Ramos, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 83 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramos+ra+1/Ramos+(RA+1)%3B+Burkitt's+Lymphoma%3B+Human/pmc11611760-93-0-7
Average 95 stars, based on 83 article reviews
Human Burkitt S Lymphoma Ramos, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 83 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ramos+ra+1/Ramos+(RA+1)%3B+Burkitt's+Lymphoma%3B+Human/pmc11611760-93-0-7
Average 95 stars, based on 83 article reviews
human burkitt s lymphoma ramos - by Bioz Stars,
2026-11
95/100 stars
Images
1) Product Images from "The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti‐ PD ‐1 antibody and paclitaxel"
Article Title: The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti‐ PD ‐1 antibody and paclitaxel
Journal: Cancer Science
doi: 10.1111/cas.16366
Figure Legend Snippet: KHK2840 is a novel human CD40 agonist. (A) Representative sensorgrams of hCD40 (left), cynomolgus monkey CD40 (middle left), rat CD40 (middle; right), and mouse CD40 (right) to KHK2840. KHK2840 was captured on the sensor chip immobilized with anti‐human IgG, and then dilutions of recombinant CD40 proteins (0.0625, 0.125, 0.250, 0.500, 1.00 μg/mL) were injected. (B) KHK2840 (red), isotype control (human anti‐DNP IgG2, gray), and positive control (human anti‐DNP IgG1, blue) bind to FcγRIIIa (left, 158F; middle, 158 V) and C1q. Data represent the mean ± SD of three experiments. (C) The in vitro expression of CD80, CD86, and IL‐12p70 in hmoDCs induced by KHK2840 (red) and isotype control (human anti‐DNP IgG2, gray). In IL‐12p70, values below the lower limit of quantification (LLOQ) were replaced with the LLOQ. Data represent the mean ± SD of three wells. The same experiments were repeated in a total of six donors. (D) The in vitro expression of CD86 and CD95 induced in Ramos cells by 0.01 (filled circle), 0.1 (blank circle), 1 (filled square) and 10 μg/mL (blank square) KHK2840 after 0.5, 4, 24, and 48 h of treatment. KHK2840 was washed out at the indicated time points. Cells were analyzed after a total of 48 h of incubation. Data represent the mean ± SD of three wells.
Techniques Used: Recombinant, Injection, Control, Positive Control, In Vitro, Expressing, Incubation
Related Articles
Cell Culture:Article Title: Bruton's tyrosine kinase activity probe and method of using Article Snippet: .. Cell lines 293H (11631-017, Invitrogen), DOHH2 (ACC 47, DSMZ) and Article Title: Potassium suppresses allosteric activation of ZAP-70-dependent T Cell Receptor signaling. Article Snippet: .. Jurkat E6.1 cells (ATCC # TIB-152), Jurkat P116 cells (ATCC # CRL-2676) and Transformation Assay:Article Title: B cell receptor modification in B cells Article Snippet: .. B Cell Engineering Optimal nucleofection parameters for Article Title: In vitro study of Listeria monocytogenes infection to murine primary and human transformed B cells. Article Snippet: Immunity to Listeria monocytogenes is largely mediated by T lymphocytes.. Recently, B lymphocytes or their secreted products are implicated to provide immunity against L. monocytogenes infection.. To understand whether L. monocytogenes can infect and kill B cells as a possible strategy to initiate an infection, we examined the effects of L. monocytogenes on a human B lymphoma (Ramos RA-1) and mouse primary B cells in vitro. Plasmid Preparation:Article Title: B cell receptor modification in B cells Article Snippet: .. B Cell Engineering Optimal nucleofection parameters for Transfection:Article Title: B cell receptor modification in B cells Article Snippet: .. B Cell Engineering Optimal nucleofection parameters for Electrical Source Imaging:Article Title: Gold nanoparticle-streptavidin conjugates for rapid and efficient screening of aptamer function in lateral flow sensors using novel CD4-binding aptamers identified through Crossover-SELEX. Article Snippet: To decrease the burden of laborious and reagent-intensive screening of modified aptamers, their binding function requires assessment in assay formats compatible with the end diagnostic application.. Here, we report on the use of an alternative and cost-effective approach: a rapid lateral flow assay (LFA) utilising streptavidin-conjugated gold nanoparticles (AuNP) as reporter molecules to screen novel ssDNA aptamers for their ability to detect CD4.. Crossover-SELEX was employed to identify CD4-targeting aptamers from a ssDNA library enriched against a recombinant human CD4 protein (hCD4) conjugated to magneticbeads and to endogenous CD4 expressed by U937 cells. |
